Magnesium Glycinate vs Citrate vs Threonate for Sleep

About one in three US adults regularly sleeps less than seven hours a night, according to CDC surveillance data. That gap has turned magnesium into one of the best-selling sleep supplements on the market — and turned a chemistry detail, the form of the mineral, into a marketing battleground. Glycinate is sold as the relaxer, citrate as the absorbable workhorse, threonate as the premium brain-targeting option. The stakes for the reader are practical: the wrong pick can mean diarrhea at effective doses, an overpriced bottle, or quietly abandoning a supplement that might have helped.

What magnesium actually does

Magnesium is a cofactor in more than 300 enzyme systems. Among them are pathways directly relevant to sleep: it supports GABA signaling, the brain's primary inhibitory neurotransmitter system, and modulates NMDA receptors involved in arousal. Observational research has linked low magnesium intake with poorer sleep quality and shorter sleep duration.

The intake gap is real. The NIH Office of Dietary Supplements sets a recommended dietary allowance of 400–420 mg/day for men and 310–320 mg/day for women, and federal survey analysis cited by the NIH found that roughly 48% of Americans take in less magnesium from food than their estimated average requirement. The tolerable upper intake level for supplemental magnesium is 350 mg/day of elemental magnesium — a number worth remembering at checkout.

What the clinical trials show is modest. A 2012 randomized, double-blind trial in the Journal of Research in Medical Sciences gave 46 older adults with insomnia 500 mg of magnesium oxide daily for eight weeks; the magnesium group reported lower insomnia severity scores, longer sleep time, better sleep efficiency and shorter sleep-onset latency versus placebo. A 2021 systematic review and meta-analysis in BMC Complementary Medicine and Therapies pooled the available trials in older adults and rated the overall evidence low-certainty: possible small gains in total sleep time, but inconsistent outcomes and a high risk of bias across studies.

The three forms, compared

Magnesium glycinate

Glycinate (also called bisglycinate) is magnesium bound to glycine, an inhibitory amino acid. It contains roughly 14% elemental magnesium by weight. Its main evidence-backed advantage is tolerability: chelated forms are less likely to cause diarrhea than inorganic salts, which matters when you take a supplement at night. There is also a plausible bonus — small Japanese trials found that 3 g of glycine before bed improved subjective sleep quality and next-day alertness in people with restricted sleep. But no published head-to-head trial has compared magnesium glycinate against citrate or threonate for sleep. Its reputation rests on tolerability plus glycine's independent data, not on direct sleep trials of the chelate itself.

Magnesium citrate

Citrate contains about 16% elemental magnesium and is consistently better absorbed than magnesium oxide; a comparison published in Magnesium Research measured substantially higher absorption of the citrate salt. The catch is pharmacology, not chemistry: magnesium citrate is an osmotic laxative, sold over the counter as a bowel preparation. At supplemental doses above roughly 300–400 mg of elemental magnesium, loose stools become common. That makes citrate a sensible, inexpensive choice for someone who is both low in magnesium and constipated — and a poor choice for anyone whose priority is an undisturbed night.

Magnesium threonate

Magnesium L-threonate was designed specifically to raise brain magnesium concentrations; it contains only about 7–8% elemental magnesium. The foundational 2010 study in Neuron showed that threonate elevated cerebrospinal-fluid magnesium in rats and improved synaptic density and memory performance. Human research is younger and smaller: a 12-week trial in older adults, published in the Journal of Alzheimer's Disease, reported improvements in executive function and attention — but the endpoints were cognitive, not sleep. Sleep-specific human evidence is limited to small, preliminary studies. You are paying a large premium per milligram of elemental magnesium for a rationale built mainly on animal data.

Why it matters

Translated into concrete decisions:

• Sensitive stomach, sleep is the goal: glycinate is the pragmatic nighttime form — well tolerated at the doses used in trials.
• Constipated or budget-conscious: citrate delivers well-absorbed magnesium cheaply; take it earlier in the evening and expect a laxative effect at higher doses.
• Considering threonate: know you are buying preliminary neuroscience, not a proven sleep aid, at roughly three to five times the cost per milligram of elemental magnesium.
• Any form: keep supplemental elemental magnesium at or below 350 mg/day (the NIH adult upper limit); the UK's NHS advises that up to 400 mg/day from supplements is unlikely to cause harm.
• Safety: separate magnesium from certain antibiotics and bisphosphonates by two to six hours, and speak to a clinician first if you have reduced kidney function, where magnesium can accumulate to dangerous levels.

Set expectations on timing, too. The positive trials ran four to eight weeks. Judging a supplement after two nights tells you nothing.

The honest counterpoint

A skeptic's objection is straightforward: the form debate is marketing. The only decent randomized trial in insomnia used oxide — the cheap form supplement brands dismiss — and the best available meta-analysis rated the evidence low-certainty. No head-to-head trial has ever compared glycinate, citrate and threonate on sleep outcomes. On a strict reading, "which type matters for sleep" has no proven answer.

That objection is fair, and it is why no responsible editor would claim any form treats insomnia. But form still matters — for the unglamorous reasons. The chelate determines tolerability, how much elemental magnesium each capsule actually delivers, and whether the co-ingredient adds anything. A form that triggers diarrhea at effective doses, or that requires six capsules to reach a trial-level dose, quietly sabotages adherence. Our editorial take, clearly labeled as such: for most readers, glycinate or citrate at a sensible elemental dose is the evidence-consistent choice; threonate is a bet on early-stage neuroscience rather than a demonstrated sleep treatment.

Bottom line

Magnesium is a cofactor, not a sedative. If your intake is low — as it is for about half of Americans — bringing it up is reasonable and low-risk within the supplemental upper limit. Choose the form by tolerability and dose delivery rather than by brain-penetration marketing, give it weeks rather than nights, and treat any benefit as what the trials actually show: small, subjective improvements in sleep, not a cure for insomnia.